Express Pharma

FEBRUARY 20, 2025

The 2025 edition will feature talks from senior executives at companies including Johnson & Johnson, AstraZeneca, Bristol Myers Squibb, UCB, Bayer, Valneva, Polpharma, and MSD. The event will also present new industry research from Simon-Kucher.

Pharmaceutical Manufacturing 101

Pharmaceutical Manufacturing Vaccines Pharmaceutical Companies Pharmaceutical Companies 101

pharmaphorum

SEPTEMBER 12, 2024

Join us for Day Two of LSX World Congress featuring presentations from top pharmaceutical companies like AstraZeneca, Takeda, Merck, Roche, Johnson & Johnson, Bayer and more. Get insights into the latest trends and innovations in the life sciences industry.

Pharmaceutical Companies 106

Pharmaceutical Companies Pharmaceutical Companies 106

Express Pharma

JANUARY 26, 2025

Scheduled to take place from January 27-30, 2025, at the World Trade Center (WTC), Dubai to be inaugurated by Satish Kumar Siven, Consul General of India to UAE, at Dubai on January 27, 2025 this event will feature participation from 65 leading Indian pharmaceutical companies.

Pharmaceutical Manufacturing 82

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Vaccines 82

Drug Patent Watch

MARCH 31, 2025

The market presents numerous opportunities for growth, including expanding into emerging markets and developing more complex generic medications. Regulatory hurdles, intellectual property disputes, and quality control issues are key challenges facing the market.

Biosimilars 52

Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

DECEMBER 30, 2024

He stressed that for India to continue strengthening its position in global markets, the pharmaceutical industry must ensure that complaints are addressed promptly and efficiently, which, in turn, could prevent public trust from eroding.

Documentation 105

Documentation Communication Packaging Pharmaceutical Companies 105

European Pharmaceutical Review

JANUARY 22, 2025

Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceutical company. This data was presented at the 2024 American Society of Psychopharmacology Annual Meeting (Poster W80). At week 4, 22.5

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies Hospitals 64

Pharma Mirror

OCTOBER 4, 2021

Despite untold investment by numerous pharmaceutical companies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation.

Pharmaceutical Companies 119

Pharmaceutical Companies Pharmaceutical Companies 119

Express Pharma

DECEMBER 17, 2024

Additionally, the speed and flexibility needed to thrive in the present competitive environment cannot be provided by traditional techniques of production system installation or reactive manufacturing planning. The industrial approach must be modernised if long-term success is to be achieved.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Pharmaceutical Companies Pharmaceutical Companies 105

Express Pharma

JANUARY 22, 2025

Established by ICT Mumbai to honour the late Dr K Anji Reddy, founder of Dr Reddys Laboratories, a visionary in Indian pharmaceuticals, the fellowship recognises individuals who have made extraordinary contributions to the advancement of the pharmaceutical and biopharmaceutical industries.

Vaccines 109

Vaccines Pharmaceutical Companies Pharmaceutical Companies 109

European Pharmaceutical Review

OCTOBER 23, 2023

Janssen Pharmaceutical Companies of Johnson & Johnson’s data were featured at the European Society for Medical Oncology (ESMO) 2023 Congress. The results presented included an evaluation of 54 patients who received TAR-200.

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Hospitals Vaccines 111

Pharma Marketing Network

MARCH 20, 2025

With the rapid expansion of digital platforms, evolving patient expectations, and the increasing role of AI-driven marketing, pharmaceutical companies and healthcare brands are allocating more resources to advertising in 2025. Regulatory agencies are demanding clearer disclosures and evidence-based claims in pharmaceutical promotions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies HIPAA Biosimilars 59

European Pharmaceutical Review

NOVEMBER 25, 2024

An increasing trend of outsourcing boosts growth of the market as pharmaceutical companies are utilising advanced testing capabilities and optimising their drug development processes. The market is furthermore expected to see a compound annual growth rate (CAGR) of 7.3 percent between 2024 and 2032.

Drug Development 52

Drug Development Biosimilars Compounding Pharmaceutical Companies 52

European Pharmaceutical Review

OCTOBER 10, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD).

Pharmaceutical Companies 109

Pharmaceutical Companies Pharmaceutical Companies Hospitals 109

Express Pharma

JUNE 13, 2024

Momna Ali, Healthcare Analyst at GlobalData, comments, “Due to the variety in the presentation of ALS development and symptoms, there have been historical difficulties in diagnosing patients in a timely manner. However, if approved, these complex biologics will command a high price, which will be of benefit to pharmaceutical companies.”

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Compounding 98

Express Pharma

JUNE 1, 2024

Pharmaceutical companies face unique challenges due to their rapid digital transformation, adopting Internet of Things (IoT), Artificial Intelligence (AI), and blockchain technologies. Cybersecurity Challenges Intellectual Property Theft: Pharmaceutical companies invest heavily in research and development.

Pharmaceutical Companies 108

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Hospitals 108

European Pharmaceutical Review

MARCH 27, 2023

The results from Janssen’s ESCAPE-TRD Phase IIIb trial presented at the European Congress of Psychiatry (EPA) 2023 indicated that esketamine NS achieved significantly higher remission rates from Week 6 and response rates as early as Day 15 in the study. percent versus 39.1 percent for quetiapine XR.

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies 103

European Pharmaceutical Review

JANUARY 12, 2024

A key producer of innovative medicines: increasing manufacturing capacity Boehringer Ingelheim’s facility in Koropi is the only industrial facility of a multinational pharmaceutical company in Greece producing innovative medicines, the company acknowledged.

Diabetes 105

Diabetes Pharmaceutical Companies Pharmaceutical Companies 105

Express Pharma

APRIL 16, 2024

Resilience in challenging times The COVID-19 pandemic presented unprecedented challenges, yet it also catalysed the growth of the Indian pharmaceutical industry. The impact of India’s pharmaceutical exports will likely improve access to cost-effective treatment for many other diseases worldwide.

Vaccines 105

Vaccines Generic Medicine Pharmaceutical Companies Pharmaceutical Companies 105

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled. However, in recent years, there has been a noticeable decline in the number of these letters being issued.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Labelling Drug Development 97

European Pharmaceutical Review

SEPTEMBER 15, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson has changed its name to Johnson & Johnson Innovative Medicine (J&J Innovative Medicine). Johnson & Johnson is bringing together its divisions under the J&J brand name.

Chemotherapy 98

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Packaging 98

Express Pharma

AUGUST 30, 2023

Krishna Sarma, Managing Partner, Corporate Law Group , said, “The entanglement of Registered Medical Practitioners (RMPs) in third-party activities involving pharmaceutical companies, coupled with the haze surrounding generic medicines, beckons for clarity. The establishment of a CPD-supporting entity hinges on fiscal resolutions.

Generic Medicine 110

Generic Medicine Dosage Compounding Pharmaceutical Companies 110

Express Pharma

MAY 6, 2024

Among the attendees, contract manufacturing organisations, service providers and experts were present. Representatives from leading pharmaceutical companies such as Merck, Bayer AG, Novartis, Takeda and Pfizer also participated in the Congress. and Produlab Pharma.

Packaging 105

Packaging Pharmaceutical Manufacturing Labelling Pharmaceutical Companies 105

European Pharmaceutical Review

AUGUST 31, 2023

[pharmaceutical companies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.

Pharmaceutical Companies 97

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Hospitals 97

pharmaphorum

OCTOBER 5, 2021

Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisation in the healthcare industry. As part of these efforts, customer experience (CX) became a key focus area to ensure customer engagement and loyalty.

Pharmaceutical Companies 118

Pharmaceutical Companies Pharmaceutical Companies 118

Eye on FDA

AUGUST 2, 2022

There are two means of gaining insight into the agency’s thinking about regulatory issues related to promotional communications by pharmaceutical companies; one is through the issuance of guidance documents, the other is through enforcement. But when it comes to enforcement things have changed greatly over the years.

Communication 88

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 88

Express Pharma

OCTOBER 16, 2024

Asiyah Nawab, Pharma Analyst at GlobalData, states, “Sanofi/Regeneron’s Dupixent has demonstrated great efficacy for patients that present with moderate-to-severe exacerbations with high blood eosinophils, while simultaneously administering their SOC.

Communication 104

Communication Pharmaceutical Companies Pharmaceutical Companies 104

PharmaShots

APRIL 25, 2023

Numerous pharmaceutical companies have developed and authorized vaccines to provide immunity against COVID-19. Despite the drenched market of covid products, many other drugs have set an impressive benchmark for pharmaceutical companies in 2021. Watch out for the full report on Dupixent tomorrow. Stay tuned!

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunity 56

Express Pharma

MAY 13, 2024

With other pharmaceutical companies entering the race for developing the first marketed therapy against bronchiectasis, the great opportunity in the market is underlined, says GlobalData , a data and analytics company.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Labelling 98

Pharmaceutical Technology

FEBRUARY 24, 2023

The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, otherwise known as net present value (NPV). It also promotes products through sales representatives and marketing agreements with other pharmaceutical companies. million in FY2021.

Diabetes 45

Diabetes Immunization Immunity Pharmaceutical Companies 45

European Pharmaceutical Review

OCTOBER 20, 2023

The first readout of two-year data from the ADjoin long-term extension study is being presented at the 2023 Annual Fall Clinical Dermatology Conference. This cytokine drives the type-2 inflammatory loop in the skin, which leads to skin barrier dysfunction, itch, skin thickening and infection.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

The Digital Apothecary

MAY 13, 2017

Educators across all healthcare spheres rely on teaching what the current standards of care and evaluation in the medical environment at present are to help them get them to their clinical experiences prepared. And the company that bought their product to launch it into a worldwide pharmaceutical company?

Diabetes 130

Diabetes Vaccines Pharmaceutical Companies Pharmaceutical Companies 130

European Pharmaceutical Review

JULY 12, 2022

Microbes developing resistance to disinfectants is a major emerging problem in pharmaceutical manufacturing cleanrooms and, if left unchecked, could present a threat to drug quality and, therefore, human health. Reducing this concentration twice, the researchers found that at the lowest concentration M. luteus and S.

Pharmaceutical Manufacturing 111

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 111

pharmaphorum

NOVEMBER 24, 2022

Citing people close to the matter, Bloomberg suggests that Mirati is the subject of takeover interest from “large pharmaceutical companies” and has been weighing up its “strategic options” including a possible sale, although it does say that no formal bids are on the table and a deal is not imminent.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Drug Patent Watch

DECEMBER 9, 2024

This includes: Preclinical studies Clinical trials Regulatory approval Manufacturing and marketing Throughout this process, pharmaceutical companies seek to protect their investments through patents. It’s a delicate balance between incentivizing research and ensuring equitable access to medicines.”

Compounding 97

Compounding Drug Development Documentation Pharmaceutical Companies 97

European Pharmaceutical Review

SEPTEMBER 21, 2023

Higher efficiency tralokinumab drug delivery Tralokinumab is at present, available in a 150mg in 1 mL pre-filled syringe, requiring four initial, and two maintenance doses with the 150mg in 1mL pre-filled syringe. It inhibits interaction with the IL-13 receptor α1 and α2 subunits (IL-13Rα1 and IL-13Rα2).

Immunization 105

Immunization Immunity Pharmaceutical Companies Pharmaceutical Companies 105

European Pharmaceutical Review

AUGUST 3, 2023

.” Implementing quality standards for medicinal cannabis Mikael Sodergren of Curaleaf International explained in an article published on EPR’s website last month: “there is a vast range of flavonoids, terpenoids, phytols and other compounds present at lower concentrations within the cannabis flower”.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

Pharma Pathway

OCTOBER 20, 2022

Alembic Pharmaceuticals Ltd. is one of the leading API & Formulations manufacturing and marketing pharmaceutical Company. Role & Responsibility: Demonstrate or present and promote products to healthcare professionals like doctors and pharmacists. Job Description. Age: Up to 24 years. Freshers Preferable.

Pharmaceutical Companies 81

Pharmaceutical Companies Pharmaceutical Companies 81